Artificial intelligence-powered liquid biopsy in cancer: a paradigm shift in cancer detection and personalized care
Machine learning paired with blood tests could soon catch cancers earlier by spotting tumor signals invisible to standard screening.
This review examines how AI and machine learning are being integrated with liquid biopsy technologies to improve cancer detection and personalized treatment. It covers applications across ctDNA analysis, CTC detection, and exosome profiling.
What the study was
- Study design
- Narrative review
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Cancer Cell International
Why it surfaced
Relevant cross-topic review bridging AI and liquid biopsy. No abstract available to assess depth.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.